Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sixth Wave Innovations Inc C.SIXW


Primary Symbol: SIXWF

Sixth Wave Innovations Inc. is a Canada-based nanotechnology company with patented technologies. The Company is focused on the extraction and detection of target substances at the molecular level using specialized molecularly imprinted polymers (MIPs). The Company’s product brands include AMIPs, IXOS and Affinity. The IXOS is a line of extraction polymers formulated for deployment in the gold mining industry. The Affinity system is using its MIPs, which are designed to capture and extract cannabinoids from filtered crude extracts without the use of traditional winterization and distillation. The Company’s patent portfolio covers extensions of the designs for extraction and purification of other critical metals including nickel, cobalt, rare earth elements, and platinum group metals. It also designs, develops and commercializes MIP solutions across a spectrum of industries.


GREY:SIXWF - Post by User

Comment by Onadimeon Jul 27, 2022 1:06pm
76 Views
Post# 34854206

RE:RE:RE:I'd make a wild bet

RE:RE:RE:I'd make a wild betHopefully they have started these preparations  as per the may 24th update.  Which from that time should be 60 -90 day. Assuming closer to 90 days 

SIXW has advanced the AMIPs™ prototype through sensitivity and cross-reactivity (selectivity against other respiratory pathogens) testing using the ZeptoMetrix NATtrol™ Respiratory Verification Panel, an industry standard panel of 22 common respiratory pathogens used for development of diagnostics, with excellent results in specificity and sensitivity. Preparations are underway for independent clinical testing and compilation of required test data for regulatory approval in Canada and the United States.
<< Previous
Bullboard Posts
Next >>